Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model

References

• BeasleyRPHwangLYLinCCChienCSHepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in TaiwanLancet19812112911336118576
   PubMed Web of Science ®Google Scholar
• TrichopoulosDBamiaCLagiouPHepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control studyJ Natl Cancer Inst20111031686169522021666
   PubMedGoogle Scholar
• El-SeragHBRudolphKLHepatocellular carcinoma: epidemiology and molecular carcinogenesisGastroenterology20071322557257617570226
   PubMed Web of Science ®Google Scholar
• BellentaniSSaccoccioGCostaGDrinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study GroupGut1997418458509462221
   PubMed Web of Science ®Google Scholar
• CalleEEKaaksROverweight, obesity and cancer: epidemiological evidence and proposed mechanismsNat Rev Cancer2004457959115286738
   PubMed Web of Science ®Google Scholar
• FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer20101272893291721351269
   PubMed Web of Science ®Google Scholar
• LeeWMHepatitis B virus infectionN Engl J Med1997337173317459392700
   PubMed Web of Science ®Google Scholar
• YangHILuSNLiawYFHepatitis B e antigen and the risk of hepatocellular carcinomaN Engl J Med200234716817412124405
   PubMed Web of Science ®Google Scholar
• ChenCJYangHISuJRisk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA levelJAMA2006295657316391218
   PubMed Web of Science ®Google Scholar
• YangHIYuenMFChanHLRisk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive scoreLancet Oncol20111256857421497551
   PubMed Web of Science ®Google Scholar
• ChanHLHuiAYWongMLGenotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinomaGut2004531494149815361502
   PubMed Web of Science ®Google Scholar
• KaoJHChenPJLaiMYChenDSBasal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriersGastroenterology200312432733412557138
   PubMed Web of Science ®Google Scholar
• YuenMFTanakaYShinkaiNRisk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levelsGut2008579810217483190
   PubMed Web of Science ®Google Scholar
• YuenMFTanakaYFongDYIndependent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis BJ Hepatol200950808818977053
   PubMed Web of Science ®Google Scholar
• ParkBKParkYNAhnSHLong-term outcome of chronic hepatitis B based on histological grade and stageJ Gastroenterol Hepatol20072238338817295771
   PubMed Web of Science ®Google Scholar
• JungKSKimSUAhnSHRisk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan)Hepatology20115388589421319193
   PubMed Web of Science ®Google Scholar
• BravoAAShethSGChopraSLiver biopsyN Engl J Med200134449550011172192
   PubMed Web of Science ®Google Scholar
• RousseletMCMichalakSDupreFSources of variability in histological scoring of chronic viral hepatitisHepatology20054125726415660389
   PubMed Web of Science ®Google Scholar
• KimSUSeoYSCheongJYFactors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis BAliment Pharmacol Ther20103249850520491742
   PubMed Web of Science ®Google Scholar
• WongGLWongVWChoiPCChanAWChanHLDevelopment of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis BAliment Pharmacol Ther2010311095110320180785
   PubMed Web of Science ®Google Scholar
• KimSUKimJKParkYNHanKHDiscordance between liver biopsy and Fibroscan(R) in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammationPLoS One20127e3223322384189
   PubMed Web of Science ®Google Scholar
• JangHWKimSUParkJYHow many valid measurements are necessary to assess liver fibrosis using FibroScan(R) in patients with chronic viral hepatitis? An analysis of subjects with at least 10 valid measurementsYonsei Med J20125333734522318821
   PubMed Web of Science ®Google Scholar
• Kim doYKimSUAhnSHUsefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis BDig Dis Sci2009541758176319005758
   PubMed Web of Science ®Google Scholar
• KimSUHanKHNamCMNatural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascitesJ Gastroenterol Hepatol2008231722172718717757
   PubMed Web of Science ®Google Scholar
• BruixJShermanMManagement of hepatocellular carcinomaHepatology2005421208123616250051
   PubMed Web of Science ®Google Scholar
• ChenGLinWShenFIloejeUHLondonWTEvansAAPast HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective studyAm J Gastroenterol20061011797180316817842
   PubMed Web of Science ®Google Scholar
• HanKHAhnSHHow to predict HCC development in patients with chronic B viral liver disease?Intervirology200548232815785086
   PubMed Web of Science ®Google Scholar
• KimHCNamCMJeeSHHanKHOhDKSuhINormal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort studyBMJ200432898315028636
   PubMed Web of Science ®Google Scholar
• HannHWFuXMyersREPredictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection – results from a clinic-based longitudinal cohortEur J Cancer20121919
   Google Scholar
• EASL Clinical Practice Guidelines: management of chronic hepatitis BJ Hepatol20095022724219054588
   PubMed Web of Science ®Google Scholar
• LokASMcMahonBJChronic hepatitis B: update 2009Hepatology20095066166219714720
   PubMed Web of Science ®Google Scholar
• LeungNRecent data on treatment of chronic hepatitis B with nucleos(t) ide analoguesHepatol Int2008216317819669301
   PubMed Web of Science ®Google Scholar